Dergiler / İstanbul Journal of Pharmacy / 2022 / Cilt: 52 - Sayı: 1

A review on hydrogen sulfide: Is it pro-nociceptive or anti-nociceptive?

Sayfa
101–107
Yayın Tarihi
2022-04-28
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It is estimated that the modification of H2S, with currently used analgesic drugs to prevent various side ef- fects and increase analgesic effects, is a promising and wise approach.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pain is sensed by the activation of painful nociceptors in the periphery or by pain mediators, such as bradykinin, serotonin, histamine, and prostaglandin, released from the damaged tissue, afferent transmission to the medulla spinalis, and by trans- mission stages to the high centers over the dorsal horn.
📊
Temel Bulgular & Veri:Hydrogen sulfide (H2S) is a modulator of T-type Ca+2 channels, especially in Cav3.2, which are known to play a critical role in the processing of pain.
💡
Sonuç & Katkı:It is estimated that the modification of H2S, with currently used analgesic drugs to prevent various side ef- fects and increase analgesic effects, is a promising and wise approach.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Hydrogen sulfide · Pain · Analgesic effect

Abstract

Pain is sensed by the activation of painful nociceptors in the periphery or by pain mediators, such as bradykinin, serotonin, histamine, and prostaglandin, released from the damaged tissue, afferent transmission to the medulla spinalis, and by trans- mission stages to the high centers over the dorsal horn. Pain, which was seen as only a warning sign in the past, is now ac- cepted as a phenomenon in itself that needs to be treated and the search for new, stronger active substances with fewer side effects in the treatment of pain is in demand. Hydrogen sulfide (H2S) is a modulator of T-type Ca+2 channels, especially in Cav3.2, which are known to play a critical role in the processing of pain. H2S can also show an anti-nociceptive effect by open- ing K+ channels and blocking nociceptors. Exciting preclinical data has demonstrated that H2S-derived Non-steroidal anti- inflammatory drugs (NSAIDs) and analgesic agents can be used to treat various types of pain. H2S increases the resistance of gastric mucosa against injury occurred by drugs used for pain relief and accelerates its repair, so it provides an advantage to derivatized drugs. In addition, H2S donors have also been shown to induce analgesia through μ-opioid receptors. Based on the studies, it is thought that the combination of H2S with opioid receptor agonists may provide an additive or even synergistic analgesic effect. It is estimated that the modification of H2S, with currently used analgesic drugs to prevent various side ef- fects and increase analgesic effects, is a promising and wise approach.

🔖

Bu Makaleye Atıf Yap

EKEN, H., TÜRKMEN, N. B., ARSLAN, R. (2022). A review on hydrogen sulfide: Is it pro-nociceptive or anti-nociceptive?. İstanbul Journal of Pharmacy, Cilt: 52 - Sayı: 1, 101–107. https://ajindex.com/articles/676228

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Aydın, O. N. (2002). Ağrı ve ağrı mekanizmalarına güncel bakış [Current inspect to pain and the pain mechanism]. ADÜ Tıp Fakül- tesi Dergisi, 3(2), 37-48. Batallé, G., Cabarga, L., & Pol, O. (2020). The inhibitory effects of slow-releasing hydrogen sulfide donors in the mechanical allo- dynia, grip strength deficits, and depressive-like behaviors associ- ated with chronic osteoarthritis pain. Antioxidants, 9(1), 31. Cabarga, L., Batallé, G., & Pol, O. (2020). Treatment with slow- releasing hydrogen sulfide donors inhibits the nociceptive and depressive-like behaviours accompanying chronic neuropathic pain: Endogenous antioxidant system activation. Journal of Psy- chopharmacology, 34(7), 737-749.
  2. Caliendo, G., Cirino, G., Santagada, V., & Wallace, J. L. (2010). Syn-thesis and biological effects of hydrogen sulfide (H2S): develop- ment of H2S-releasing drugs as pharmaceuticals. Journal of Me- dicinal Chemistry, 53(17), 6275-6286.
  3. Cenac, N., Castro, M., Desormeaux, C., Colin, P., Sie, M., Ranger, M., & Vergnolle, N. (2016). A novel orally administered trimebutine compound (GIC‐1001) is anti‐nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide‐releasing ca- pacity in mice. European Journal of Pain, 20(5), 723-730.
  4. Cetin, Z., Gunduz, O., Topuz, R. D., Dokmeci, D., Karadag, H. C., & Ulugol, A. (2021). The Role of Hydrogen Sulfide in the Develop- ment of Tolerance and Dependence to Morphine in Mice. Neuro- psychobiology, 80(3), 264-270.
  5. Cunha, T. M., Dal-Secco, D., Verri Jr, W. A., Guerrero, A. T., Souza,G. R., Vieira, S. M.,. & Cunha, F. Q. (2008). Dual role of hydrogen sulfide in mechanical inflammatory hypernociception. Euro- pean journal Journal of pharmacologyPharmacology, 590(1-3), 127-135.
  6. Cury, Y., Picolo, G., Gutierrez, V. P., & Ferreira, S. H. (2011). Pain and analgesia: The dual effect of nitric oxide in the nociceptive sys- tem. Nitric oxide, 25(3), 243-254.
  7. De Cicco, P., Panza, E., Ercolano, G., Armogida, C., Sessa, G., Pirozzi, G.,. & Ianaro, A. (2016). ATB-346, a novel hydrogen sulfide-releas- ing anti-inflammatory drug, induces apoptosis of human mela- noma cells and inhibits melanoma development in vivo. Pharma- cological research, 114, 67-73.
  8. Distrutti, E. (2011). Hydrogen sulphide and pain. Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)(Discontinued), 10(2), 123-132.
  9. Distrutti, E., Sediari, L., Mencarelli, A., Renga, B., Orlandi, S., An- tonelli, E.,. & Fiorucci